Alnylam Pharmaceuticals, Inc.

Steward Partners Investment Advisory, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

1,425

Value ($000)

567

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	567	0.0%	1,425	12/31/2025
2025 Q3	11/12/2025	658	0.0%	1,443	9/30/2025
2025 Q2	8/12/2025	442	0.0%	1,357	6/30/2025
2025 Q1	5/13/2025	287	0.0%	1,062	3/31/2025
2024 Q4	2/6/2025	221	0.0%	940	12/31/2024
2024 Q3	11/14/2024	248	0.0%	900	9/30/2024
2024 Q2	8/8/2024	216	0.0%	890	6/30/2024
2024 Q1	5/15/2024	107	0.0%	715	3/31/2024
2023 Q4	2/12/2024	92	0.0%	480	12/31/2023
2023 Q3	11/13/2023	74	0.0%	420	9/30/2023
2023 Q2	8/14/2023	77	0.0%	405	6/30/2023
2023 Q1	5/15/2023	81	0.0%	405	3/31/2023
2022 Q4	2/15/2023	101	0.0%	423	12/31/2022
2022 Q3	11/10/2022	81	0.0%	405	9/30/2022
2022 Q2	8/4/2022	66	0.0%	455	6/30/2022
2022 Q1	5/2/2022	76	0.0%	463	3/31/2022
2021 Q4	2/8/2022	128	0.0%	754	12/31/2021
2021 Q3	11/12/2021	142	0.0%	754	9/30/2021
2021 Q2	8/13/2021	128	0.0%	754	6/30/2021
2021 Q1	5/14/2021	462	0.0%	3,275	3/31/2021
2020 Q4	2/11/2021	98	0.0%	754	12/31/2020
2020 Q3	10/30/2020	127	0.0%	874	9/30/2020
2020 Q2	8/6/2020	129	0.0%	874	6/30/2020
2020 Q1	4/29/2020	92	0.0%	850	3/31/2020
2019 Q4	1/17/2020	131	0.0%	1,145	12/31/2019